Larvol Delta - The-CoVIg-study-Randomized-Open-Label-Trial-Evaluating-Efficacy-and-Safety-of-Intravenous-Immunoglobulin-IVIg-Privigen-as-Addon-to-SoC-Versus-SoC-Alone-for-Coronavirus-Disease-2019-COVID19-in-Patients-with-Severely-Impaired-Bcell-Function

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

remdesivir - Generic mfg.

Privigen (human immune globulin intravenous 10%) - CSL Behring

https://euclinicaltrials.eu/ctis-public/view/2025-522756-97-00

Feb 18, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next